nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—CYP2C9—Bexarotene—hematologic cancer	0.0463	0.0628	CbGbCtD
Quazepam—CYP2C9—Idarubicin—hematologic cancer	0.0384	0.0521	CbGbCtD
Quazepam—CYP2C19—Bortezomib—hematologic cancer	0.0342	0.0463	CbGbCtD
Quazepam—CYP2C19—Thalidomide—hematologic cancer	0.0298	0.0403	CbGbCtD
Quazepam—CYP2C9—Bortezomib—hematologic cancer	0.0284	0.0385	CbGbCtD
Quazepam—CYP2C19—Teniposide—hematologic cancer	0.0284	0.0385	CbGbCtD
Quazepam—CYP3A4—Bexarotene—hematologic cancer	0.027	0.0365	CbGbCtD
Quazepam—CYP2C19—Ifosfamide—hematologic cancer	0.0262	0.0355	CbGbCtD
Quazepam—CYP3A4—Lomustine—hematologic cancer	0.0251	0.034	CbGbCtD
Quazepam—CYP3A4—Busulfan—hematologic cancer	0.0251	0.034	CbGbCtD
Quazepam—CYP2C19—Imatinib—hematologic cancer	0.025	0.0339	CbGbCtD
Quazepam—CYP2C9—Thalidomide—hematologic cancer	0.0247	0.0335	CbGbCtD
Quazepam—CYP2C9—Teniposide—hematologic cancer	0.0236	0.032	CbGbCtD
Quazepam—CYP3A4—Thiotepa—hematologic cancer	0.0223	0.0303	CbGbCtD
Quazepam—CYP2C9—Ifosfamide—hematologic cancer	0.0218	0.0295	CbGbCtD
Quazepam—CYP2C9—Imatinib—hematologic cancer	0.0208	0.0282	CbGbCtD
Quazepam—CYP2C9—Nilotinib—hematologic cancer	0.0189	0.0256	CbGbCtD
Quazepam—CYP3A4—Methoxsalen—hematologic cancer	0.0174	0.0235	CbGbCtD
Quazepam—CYP3A4—Bortezomib—hematologic cancer	0.0165	0.0224	CbGbCtD
Quazepam—CYP2C19—Prednisone—hematologic cancer	0.0165	0.0224	CbGbCtD
Quazepam—CYP3A4—Daunorubicin—hematologic cancer	0.0158	0.0214	CbGbCtD
Quazepam—CYP3A4—Cytarabine—hematologic cancer	0.0139	0.0189	CbGbCtD
Quazepam—CYP3A4—Teniposide—hematologic cancer	0.0137	0.0186	CbGbCtD
Quazepam—CYP3A4—Ifosfamide—hematologic cancer	0.0127	0.0172	CbGbCtD
Quazepam—CYP3A4—Imatinib—hematologic cancer	0.0121	0.0164	CbGbCtD
Quazepam—CYP3A4—Ruxolitinib—hematologic cancer	0.0114	0.0154	CbGbCtD
Quazepam—CYP3A4—Nilotinib—hematologic cancer	0.011	0.0149	CbGbCtD
Quazepam—CYP3A4—Vinorelbine—hematologic cancer	0.0109	0.0148	CbGbCtD
Quazepam—CYP2C9—Cisplatin—hematologic cancer	0.0106	0.0144	CbGbCtD
Quazepam—CYP2C19—Dexamethasone—hematologic cancer	0.0103	0.014	CbGbCtD
Quazepam—CYP3A4—Triamcinolone—hematologic cancer	0.00997	0.0135	CbGbCtD
Quazepam—CYP3A4—Dasatinib—hematologic cancer	0.00972	0.0132	CbGbCtD
Quazepam—CYP3A4—Mitoxantrone—hematologic cancer	0.0096	0.013	CbGbCtD
Quazepam—CYP2C9—Dexamethasone—hematologic cancer	0.00856	0.0116	CbGbCtD
Quazepam—CYP3A4—Betamethasone—hematologic cancer	0.00856	0.0116	CbGbCtD
Quazepam—CYP3A4—Prednisolone—hematologic cancer	0.00844	0.0114	CbGbCtD
Quazepam—CYP3A4—Prednisone—hematologic cancer	0.00797	0.0108	CbGbCtD
Quazepam—CYP3A4—Irinotecan—hematologic cancer	0.00756	0.0102	CbGbCtD
Quazepam—CYP3A4—Vinblastine—hematologic cancer	0.00672	0.00911	CbGbCtD
Quazepam—CYP3A4—Vincristine—hematologic cancer	0.00661	0.00896	CbGbCtD
Quazepam—CYP3A4—Etoposide—hematologic cancer	0.00605	0.00821	CbGbCtD
Quazepam—CYP3A4—Dexamethasone—hematologic cancer	0.00498	0.00675	CbGbCtD
Quazepam—CYP3A4—Doxorubicin—hematologic cancer	0.00413	0.0056	CbGbCtD
Quazepam—Thinking abnormal—Daunorubicin—hematologic cancer	0.00356	0.0206	CcSEcCtD
Quazepam—Thinking abnormal—Pentostatin—hematologic cancer	0.00354	0.0205	CcSEcCtD
Quazepam—Mental disability—Nelarabine—hematologic cancer	0.00302	0.0175	CcSEcCtD
Quazepam—Thinking abnormal—Bexarotene—hematologic cancer	0.00293	0.0169	CcSEcCtD
Quazepam—Mental disability—Daunorubicin—hematologic cancer	0.00283	0.0163	CcSEcCtD
Quazepam—Mental disability—Pentostatin—hematologic cancer	0.00281	0.0163	CcSEcCtD
Quazepam—Mental disability—Bexarotene—hematologic cancer	0.00233	0.0135	CcSEcCtD
Quazepam—Withdrawal syndrome—Prednisone—hematologic cancer	0.00227	0.0131	CcSEcCtD
Quazepam—Thinking abnormal—Thalidomide—hematologic cancer	0.00195	0.0113	CcSEcCtD
Quazepam—Thinking abnormal—Carmustine—hematologic cancer	0.00187	0.0108	CcSEcCtD
Quazepam—Dry mouth—Vorinostat—hematologic cancer	0.00175	0.0101	CcSEcCtD
Quazepam—Fatigue—Ruxolitinib—hematologic cancer	0.00175	0.0101	CcSEcCtD
Quazepam—Mental disability—Thalidomide—hematologic cancer	0.00155	0.00894	CcSEcCtD
Quazepam—Drowsiness—Procarbazine—hematologic cancer	0.00153	0.00885	CcSEcCtD
Quazepam—Mental disability—Carmustine—hematologic cancer	0.00149	0.00859	CcSEcCtD
Quazepam—Fatigue—Vorinostat—hematologic cancer	0.00148	0.00855	CcSEcCtD
Quazepam—Asthenia—Ruxolitinib—hematologic cancer	0.00146	0.00841	CcSEcCtD
Quazepam—Dizziness—Ruxolitinib—hematologic cancer	0.00134	0.00776	CcSEcCtD
Quazepam—Headache—Ruxolitinib—hematologic cancer	0.00127	0.00735	CcSEcCtD
Quazepam—Asthenia—Vorinostat—hematologic cancer	0.00123	0.00711	CcSEcCtD
Quazepam—Dry mouth—Daunorubicin—hematologic cancer	0.00119	0.00686	CcSEcCtD
Quazepam—Drowsiness—Hydroxyurea—hematologic cancer	0.00118	0.00685	CcSEcCtD
Quazepam—Dry mouth—Anagrelide—hematologic cancer	0.00118	0.00683	CcSEcCtD
Quazepam—Dizziness—Vorinostat—hematologic cancer	0.00113	0.00656	CcSEcCtD
Quazepam—Somnolence—Nelarabine—hematologic cancer	0.0011	0.00638	CcSEcCtD
Quazepam—Headache—Vorinostat—hematologic cancer	0.00107	0.00621	CcSEcCtD
Quazepam—Fatigue—Nelarabine—hematologic cancer	0.00107	0.00619	CcSEcCtD
Quazepam—Dyspepsia—Methoxsalen—hematologic cancer	0.00107	0.00618	CcSEcCtD
Quazepam—Somnolence—Clofarabine—hematologic cancer	0.00103	0.00597	CcSEcCtD
Quazepam—Somnolence—Daunorubicin—hematologic cancer	0.00103	0.00597	CcSEcCtD
Quazepam—Somnolence—Anagrelide—hematologic cancer	0.00103	0.00595	CcSEcCtD
Quazepam—Somnolence—Pentostatin—hematologic cancer	0.00103	0.00595	CcSEcCtD
Quazepam—Dry mouth—Busulfan—hematologic cancer	0.00103	0.00593	CcSEcCtD
Quazepam—Dyspepsia—Pentostatin—hematologic cancer	0.00102	0.00589	CcSEcCtD
Quazepam—Dyspepsia—Anagrelide—hematologic cancer	0.00102	0.00589	CcSEcCtD
Quazepam—Fatigue—Clofarabine—hematologic cancer	0.001	0.00579	CcSEcCtD
Quazepam—Fatigue—Daunorubicin—hematologic cancer	0.001	0.00579	CcSEcCtD
Quazepam—Fatigue—Anagrelide—hematologic cancer	0.000998	0.00577	CcSEcCtD
Quazepam—Fatigue—Pentostatin—hematologic cancer	0.000998	0.00577	CcSEcCtD
Quazepam—Drowsiness—Thalidomide—hematologic cancer	0.000997	0.00576	CcSEcCtD
Quazepam—Dry mouth—Procarbazine—hematologic cancer	0.000996	0.00576	CcSEcCtD
Quazepam—Dry mouth—Bexarotene—hematologic cancer	0.000976	0.00564	CcSEcCtD
Quazepam—Drowsiness—Alitretinoin—hematologic cancer	0.000948	0.00548	CcSEcCtD
Quazepam—Dry mouth—Nilotinib—hematologic cancer	0.000902	0.00521	CcSEcCtD
Quazepam—Dry mouth—Imatinib—hematologic cancer	0.000897	0.00518	CcSEcCtD
Quazepam—Somnolence—Busulfan—hematologic cancer	0.000894	0.00517	CcSEcCtD
Quazepam—Asthenia—Nelarabine—hematologic cancer	0.000891	0.00515	CcSEcCtD
Quazepam—Drowsiness—Mitoxantrone—hematologic cancer	0.00089	0.00515	CcSEcCtD
Quazepam—Dyspepsia—Busulfan—hematologic cancer	0.000886	0.00512	CcSEcCtD
Quazepam—Somnolence—Procarbazine—hematologic cancer	0.000868	0.00502	CcSEcCtD
Quazepam—Fatigue—Busulfan—hematologic cancer	0.000867	0.00502	CcSEcCtD
Quazepam—Somnolence—Dasatinib—hematologic cancer	0.000851	0.00492	CcSEcCtD
Quazepam—Somnolence—Bexarotene—hematologic cancer	0.000851	0.00492	CcSEcCtD
Quazepam—Dyspepsia—Dasatinib—hematologic cancer	0.000842	0.00487	CcSEcCtD
Quazepam—Dyspepsia—Bexarotene—hematologic cancer	0.000842	0.00487	CcSEcCtD
Quazepam—Fatigue—Procarbazine—hematologic cancer	0.000841	0.00487	CcSEcCtD
Quazepam—Dyspepsia—Fludarabine—hematologic cancer	0.00084	0.00486	CcSEcCtD
Quazepam—Asthenia—Clofarabine—hematologic cancer	0.000834	0.00482	CcSEcCtD
Quazepam—Asthenia—Daunorubicin—hematologic cancer	0.000834	0.00482	CcSEcCtD
Quazepam—Asthenia—Pentostatin—hematologic cancer	0.00083	0.0048	CcSEcCtD
Quazepam—Asthenia—Anagrelide—hematologic cancer	0.00083	0.0048	CcSEcCtD
Quazepam—Fatigue—Bexarotene—hematologic cancer	0.000825	0.00477	CcSEcCtD
Quazepam—Fatigue—Dasatinib—hematologic cancer	0.000825	0.00477	CcSEcCtD
Quazepam—Fatigue—Fludarabine—hematologic cancer	0.000823	0.00476	CcSEcCtD
Quazepam—Dizziness—Nelarabine—hematologic cancer	0.000821	0.00475	CcSEcCtD
Quazepam—Thinking abnormal—Epirubicin—hematologic cancer	0.00081	0.00469	CcSEcCtD
Quazepam—Dizziness—Methoxsalen—hematologic cancer	0.000802	0.00464	CcSEcCtD
Quazepam—Dyspepsia—Chlorambucil—hematologic cancer	0.000796	0.0046	CcSEcCtD
Quazepam—Dry mouth—Lenalidomide—hematologic cancer	0.000782	0.00452	CcSEcCtD
Quazepam—Somnolence—Imatinib—hematologic cancer	0.000781	0.00452	CcSEcCtD
Quazepam—Fatigue—Chlorambucil—hematologic cancer	0.000779	0.00451	CcSEcCtD
Quazepam—Asthenia—Teniposide—hematologic cancer	0.000779	0.0045	CcSEcCtD
Quazepam—Dyspepsia—Nilotinib—hematologic cancer	0.000778	0.0045	CcSEcCtD
Quazepam—Headache—Nelarabine—hematologic cancer	0.000778	0.0045	CcSEcCtD
Quazepam—Dyspepsia—Imatinib—hematologic cancer	0.000774	0.00447	CcSEcCtD
Quazepam—Dizziness—Clofarabine—hematologic cancer	0.000769	0.00444	CcSEcCtD
Quazepam—Dizziness—Daunorubicin—hematologic cancer	0.000769	0.00444	CcSEcCtD
Quazepam—Somnolence—Cladribine—hematologic cancer	0.000768	0.00444	CcSEcCtD
Quazepam—Dizziness—Pentostatin—hematologic cancer	0.000765	0.00442	CcSEcCtD
Quazepam—Dizziness—Anagrelide—hematologic cancer	0.000765	0.00442	CcSEcCtD
Quazepam—Fatigue—Nilotinib—hematologic cancer	0.000762	0.00441	CcSEcCtD
Quazepam—Headache—Methoxsalen—hematologic cancer	0.00076	0.00439	CcSEcCtD
Quazepam—Fatigue—Imatinib—hematologic cancer	0.000758	0.00438	CcSEcCtD
Quazepam—Thinking abnormal—Doxorubicin—hematologic cancer	0.00075	0.00434	CcSEcCtD
Quazepam—Fatigue—Cladribine—hematologic cancer	0.000745	0.00431	CcSEcCtD
Quazepam—Headache—Daunorubicin—hematologic cancer	0.000728	0.00421	CcSEcCtD
Quazepam—Headache—Clofarabine—hematologic cancer	0.000728	0.00421	CcSEcCtD
Quazepam—Headache—Anagrelide—hematologic cancer	0.000725	0.00419	CcSEcCtD
Quazepam—Headache—Pentostatin—hematologic cancer	0.000725	0.00419	CcSEcCtD
Quazepam—Asthenia—Busulfan—hematologic cancer	0.000722	0.00417	CcSEcCtD
Quazepam—Asthenia—Procarbazine—hematologic cancer	0.0007	0.00405	CcSEcCtD
Quazepam—Headache—Idarubicin—hematologic cancer	0.000699	0.00404	CcSEcCtD
Quazepam—Dyspepsia—Melphalan—hematologic cancer	0.000693	0.00401	CcSEcCtD
Quazepam—Asthenia—Dasatinib—hematologic cancer	0.000686	0.00397	CcSEcCtD
Quazepam—Asthenia—Bexarotene—hematologic cancer	0.000686	0.00397	CcSEcCtD
Quazepam—Asthenia—Fludarabine—hematologic cancer	0.000685	0.00396	CcSEcCtD
Quazepam—Somnolence—Lenalidomide—hematologic cancer	0.000681	0.00394	CcSEcCtD
Quazepam—Headache—Teniposide—hematologic cancer	0.00068	0.00393	CcSEcCtD
Quazepam—Fatigue—Melphalan—hematologic cancer	0.000679	0.00393	CcSEcCtD
Quazepam—Dyspepsia—Lenalidomide—hematologic cancer	0.000674	0.0039	CcSEcCtD
Quazepam—Somnolence—Hydroxyurea—hematologic cancer	0.000671	0.00388	CcSEcCtD
Quazepam—Dizziness—Busulfan—hematologic cancer	0.000665	0.00385	CcSEcCtD
Quazepam—Dyspepsia—Hydroxyurea—hematologic cancer	0.000665	0.00384	CcSEcCtD
Quazepam—Fatigue—Lenalidomide—hematologic cancer	0.00066	0.00382	CcSEcCtD
Quazepam—Fatigue—Hydroxyurea—hematologic cancer	0.000651	0.00377	CcSEcCtD
Quazepam—Dry mouth—Thalidomide—hematologic cancer	0.000649	0.00375	CcSEcCtD
Quazepam—Asthenia—Chlorambucil—hematologic cancer	0.000648	0.00375	CcSEcCtD
Quazepam—Dizziness—Procarbazine—hematologic cancer	0.000645	0.00373	CcSEcCtD
Quazepam—Mental disability—Epirubicin—hematologic cancer	0.000644	0.00372	CcSEcCtD
Quazepam—Asthenia—Nilotinib—hematologic cancer	0.000634	0.00367	CcSEcCtD
Quazepam—Dizziness—Bexarotene—hematologic cancer	0.000633	0.00366	CcSEcCtD
Quazepam—Dizziness—Dasatinib—hematologic cancer	0.000633	0.00366	CcSEcCtD
Quazepam—Asthenia—Imatinib—hematologic cancer	0.000631	0.00365	CcSEcCtD
Quazepam—Headache—Busulfan—hematologic cancer	0.00063	0.00364	CcSEcCtD
Quazepam—Dyspepsia—Bortezomib—hematologic cancer	0.000621	0.00359	CcSEcCtD
Quazepam—Asthenia—Cladribine—hematologic cancer	0.00062	0.00358	CcSEcCtD
Quazepam—Dry mouth—Alitretinoin—hematologic cancer	0.000617	0.00357	CcSEcCtD
Quazepam—Headache—Procarbazine—hematologic cancer	0.000611	0.00354	CcSEcCtD
Quazepam—Fatigue—Bortezomib—hematologic cancer	0.000608	0.00351	CcSEcCtD
Quazepam—Headache—Dasatinib—hematologic cancer	0.000599	0.00347	CcSEcCtD
Quazepam—Headache—Bexarotene—hematologic cancer	0.000599	0.00347	CcSEcCtD
Quazepam—Headache—Fludarabine—hematologic cancer	0.000598	0.00346	CcSEcCtD
Quazepam—Mental disability—Doxorubicin—hematologic cancer	0.000596	0.00344	CcSEcCtD
Quazepam—Asthenia—Vinblastine—hematologic cancer	0.000594	0.00344	CcSEcCtD
Quazepam—Fatigue—Vinorelbine—hematologic cancer	0.000593	0.00343	CcSEcCtD
Quazepam—Dizziness—Nilotinib—hematologic cancer	0.000585	0.00338	CcSEcCtD
Quazepam—Somnolence—Thiotepa—hematologic cancer	0.000584	0.00338	CcSEcCtD
Quazepam—Dizziness—Imatinib—hematologic cancer	0.000581	0.00336	CcSEcCtD
Quazepam—Dyspepsia—Thiotepa—hematologic cancer	0.000579	0.00335	CcSEcCtD
Quazepam—Dizziness—Cladribine—hematologic cancer	0.000571	0.0033	CcSEcCtD
Quazepam—Fatigue—Thiotepa—hematologic cancer	0.000567	0.00328	CcSEcCtD
Quazepam—Asthenia—Melphalan—hematologic cancer	0.000565	0.00327	CcSEcCtD
Quazepam—Somnolence—Thalidomide—hematologic cancer	0.000565	0.00327	CcSEcCtD
Quazepam—Dyspepsia—Thalidomide—hematologic cancer	0.00056	0.00324	CcSEcCtD
Quazepam—Headache—Nilotinib—hematologic cancer	0.000554	0.0032	CcSEcCtD
Quazepam—Headache—Imatinib—hematologic cancer	0.000551	0.00318	CcSEcCtD
Quazepam—Asthenia—Lenalidomide—hematologic cancer	0.00055	0.00318	CcSEcCtD
Quazepam—Fatigue—Thalidomide—hematologic cancer	0.000548	0.00317	CcSEcCtD
Quazepam—Dizziness—Vinblastine—hematologic cancer	0.000548	0.00317	CcSEcCtD
Quazepam—Somnolence—Carmustine—hematologic cancer	0.000543	0.00314	CcSEcCtD
Quazepam—Asthenia—Hydroxyurea—hematologic cancer	0.000542	0.00313	CcSEcCtD
Quazepam—Headache—Cladribine—hematologic cancer	0.000541	0.00313	CcSEcCtD
Quazepam—Somnolence—Alitretinoin—hematologic cancer	0.000538	0.00311	CcSEcCtD
Quazepam—Dyspepsia—Alitretinoin—hematologic cancer	0.000532	0.00308	CcSEcCtD
Quazepam—Somnolence—Ifosfamide—hematologic cancer	0.000531	0.00307	CcSEcCtD
Quazepam—Fatigue—Alitretinoin—hematologic cancer	0.000522	0.00302	CcSEcCtD
Quazepam—Headache—Vinblastine—hematologic cancer	0.000519	0.003	CcSEcCtD
Quazepam—Fatigue—Ifosfamide—hematologic cancer	0.000515	0.00298	CcSEcCtD
Quazepam—Dizziness—Lenalidomide—hematologic cancer	0.000507	0.00293	CcSEcCtD
Quazepam—Asthenia—Bortezomib—hematologic cancer	0.000506	0.00292	CcSEcCtD
Quazepam—Somnolence—Irinotecan—hematologic cancer	0.000505	0.00292	CcSEcCtD
Quazepam—Somnolence—Mitoxantrone—hematologic cancer	0.000505	0.00292	CcSEcCtD
Quazepam—Fatigue—Vincristine—hematologic cancer	0.000503	0.00291	CcSEcCtD
Quazepam—Asthenia—Bleomycin—hematologic cancer	0.000502	0.0029	CcSEcCtD
Quazepam—Dyspepsia—Irinotecan—hematologic cancer	0.0005	0.00289	CcSEcCtD
Quazepam—Dyspepsia—Mitoxantrone—hematologic cancer	0.0005	0.00289	CcSEcCtD
Quazepam—Dizziness—Hydroxyurea—hematologic cancer	0.000499	0.00289	CcSEcCtD
Quazepam—Asthenia—Vinorelbine—hematologic cancer	0.000494	0.00286	CcSEcCtD
Quazepam—Somnolence—Gemcitabine—hematologic cancer	0.000492	0.00284	CcSEcCtD
Quazepam—Fatigue—Irinotecan—hematologic cancer	0.000489	0.00283	CcSEcCtD
Quazepam—Fatigue—Mitoxantrone—hematologic cancer	0.000489	0.00283	CcSEcCtD
Quazepam—Headache—Lenalidomide—hematologic cancer	0.00048	0.00277	CcSEcCtD
Quazepam—Fatigue—Gemcitabine—hematologic cancer	0.000477	0.00276	CcSEcCtD
Quazepam—Headache—Hydroxyurea—hematologic cancer	0.000473	0.00274	CcSEcCtD
Quazepam—Asthenia—Thiotepa—hematologic cancer	0.000472	0.00273	CcSEcCtD
Quazepam—Dizziness—Bortezomib—hematologic cancer	0.000466	0.0027	CcSEcCtD
Quazepam—Asthenia—Thalidomide—hematologic cancer	0.000456	0.00264	CcSEcCtD
Quazepam—Dizziness—Vinorelbine—hematologic cancer	0.000455	0.00263	CcSEcCtD
Quazepam—Drowsiness—Methotrexate—hematologic cancer	0.000443	0.00256	CcSEcCtD
Quazepam—Headache—Bortezomib—hematologic cancer	0.000442	0.00255	CcSEcCtD
Quazepam—Asthenia—Carmustine—hematologic cancer	0.000438	0.00253	CcSEcCtD
Quazepam—Dry mouth—Triamcinolone—hematologic cancer	0.000437	0.00253	CcSEcCtD
Quazepam—Dizziness—Thiotepa—hematologic cancer	0.000435	0.00251	CcSEcCtD
Quazepam—Asthenia—Alitretinoin—hematologic cancer	0.000434	0.00251	CcSEcCtD
Quazepam—Headache—Vinorelbine—hematologic cancer	0.000431	0.00249	CcSEcCtD
Quazepam—Asthenia—Ifosfamide—hematologic cancer	0.000429	0.00248	CcSEcCtD
Quazepam—Dizziness—Thalidomide—hematologic cancer	0.00042	0.00243	CcSEcCtD
Quazepam—Somnolence—Etoposide—hematologic cancer	0.00042	0.00243	CcSEcCtD
Quazepam—Asthenia—Vincristine—hematologic cancer	0.000418	0.00242	CcSEcCtD
Quazepam—Drowsiness—Epirubicin—hematologic cancer	0.000415	0.0024	CcSEcCtD
Quazepam—Headache—Thiotepa—hematologic cancer	0.000412	0.00238	CcSEcCtD
Quazepam—Asthenia—Mitoxantrone—hematologic cancer	0.000407	0.00235	CcSEcCtD
Quazepam—Asthenia—Irinotecan—hematologic cancer	0.000407	0.00235	CcSEcCtD
Quazepam—Fatigue—Etoposide—hematologic cancer	0.000407	0.00235	CcSEcCtD
Quazepam—Dizziness—Carmustine—hematologic cancer	0.000404	0.00233	CcSEcCtD
Quazepam—Dizziness—Alitretinoin—hematologic cancer	0.0004	0.00231	CcSEcCtD
Quazepam—Headache—Thalidomide—hematologic cancer	0.000398	0.0023	CcSEcCtD
Quazepam—Asthenia—Gemcitabine—hematologic cancer	0.000397	0.00229	CcSEcCtD
Quazepam—Dizziness—Ifosfamide—hematologic cancer	0.000395	0.00229	CcSEcCtD
Quazepam—Dizziness—Vincristine—hematologic cancer	0.000385	0.00223	CcSEcCtD
Quazepam—Drowsiness—Doxorubicin—hematologic cancer	0.000384	0.00222	CcSEcCtD
Quazepam—Headache—Carmustine—hematologic cancer	0.000383	0.00221	CcSEcCtD
Quazepam—Headache—Alitretinoin—hematologic cancer	0.000379	0.00219	CcSEcCtD
Quazepam—Dyspepsia—Triamcinolone—hematologic cancer	0.000377	0.00218	CcSEcCtD
Quazepam—Dizziness—Irinotecan—hematologic cancer	0.000375	0.00217	CcSEcCtD
Quazepam—Asthenia—Cisplatin—hematologic cancer	0.00037	0.00214	CcSEcCtD
Quazepam—Fatigue—Triamcinolone—hematologic cancer	0.000369	0.00213	CcSEcCtD
Quazepam—Headache—Vincristine—hematologic cancer	0.000365	0.00211	CcSEcCtD
Quazepam—Headache—Irinotecan—hematologic cancer	0.000356	0.00206	CcSEcCtD
Quazepam—Headache—Mitoxantrone—hematologic cancer	0.000356	0.00206	CcSEcCtD
Quazepam—Headache—Gemcitabine—hematologic cancer	0.000346	0.002	CcSEcCtD
Quazepam—Dyspepsia—Betamethasone—hematologic cancer	0.000342	0.00198	CcSEcCtD
Quazepam—Dyspepsia—Dexamethasone—hematologic cancer	0.000342	0.00198	CcSEcCtD
Quazepam—Asthenia—Etoposide—hematologic cancer	0.000339	0.00196	CcSEcCtD
Quazepam—Fatigue—Dexamethasone—hematologic cancer	0.000335	0.00194	CcSEcCtD
Quazepam—Fatigue—Betamethasone—hematologic cancer	0.000335	0.00194	CcSEcCtD
Quazepam—Dizziness—Etoposide—hematologic cancer	0.000312	0.00181	CcSEcCtD
Quazepam—Dizziness—Prednisolone—hematologic cancer	0.000308	0.00178	CcSEcCtD
Quazepam—Asthenia—Triamcinolone—hematologic cancer	0.000307	0.00178	CcSEcCtD
Quazepam—Dyspepsia—Prednisone—hematologic cancer	0.000298	0.00172	CcSEcCtD
Quazepam—Headache—Etoposide—hematologic cancer	0.000296	0.00171	CcSEcCtD
Quazepam—Fatigue—Prednisone—hematologic cancer	0.000292	0.00169	CcSEcCtD
Quazepam—Headache—Prednisolone—hematologic cancer	0.000292	0.00169	CcSEcCtD
Quazepam—Dizziness—Triamcinolone—hematologic cancer	0.000283	0.00164	CcSEcCtD
Quazepam—Asthenia—Betamethasone—hematologic cancer	0.000279	0.00161	CcSEcCtD
Quazepam—Asthenia—Dexamethasone—hematologic cancer	0.000279	0.00161	CcSEcCtD
Quazepam—Dry mouth—Epirubicin—hematologic cancer	0.00027	0.00156	CcSEcCtD
Quazepam—Headache—Triamcinolone—hematologic cancer	0.000268	0.00155	CcSEcCtD
Quazepam—Dizziness—Dexamethasone—hematologic cancer	0.000257	0.00149	CcSEcCtD
Quazepam—Dizziness—Betamethasone—hematologic cancer	0.000257	0.00149	CcSEcCtD
Quazepam—Somnolence—Methotrexate—hematologic cancer	0.000251	0.00145	CcSEcCtD
Quazepam—Dry mouth—Doxorubicin—hematologic cancer	0.00025	0.00144	CcSEcCtD
Quazepam—Dyspepsia—Methotrexate—hematologic cancer	0.000249	0.00144	CcSEcCtD
Quazepam—Fatigue—Methotrexate—hematologic cancer	0.000244	0.00141	CcSEcCtD
Quazepam—Headache—Dexamethasone—hematologic cancer	0.000243	0.00141	CcSEcCtD
Quazepam—Headache—Betamethasone—hematologic cancer	0.000243	0.00141	CcSEcCtD
Quazepam—Asthenia—Prednisone—hematologic cancer	0.000243	0.0014	CcSEcCtD
Quazepam—Somnolence—Epirubicin—hematologic cancer	0.000235	0.00136	CcSEcCtD
Quazepam—Dyspepsia—Epirubicin—hematologic cancer	0.000233	0.00135	CcSEcCtD
Quazepam—Fatigue—Epirubicin—hematologic cancer	0.000228	0.00132	CcSEcCtD
Quazepam—Dizziness—Prednisone—hematologic cancer	0.000224	0.00129	CcSEcCtD
Quazepam—Somnolence—Doxorubicin—hematologic cancer	0.000218	0.00126	CcSEcCtD
Quazepam—Dyspepsia—Doxorubicin—hematologic cancer	0.000216	0.00125	CcSEcCtD
Quazepam—Headache—Prednisone—hematologic cancer	0.000212	0.00123	CcSEcCtD
Quazepam—Fatigue—Doxorubicin—hematologic cancer	0.000211	0.00122	CcSEcCtD
Quazepam—Asthenia—Methotrexate—hematologic cancer	0.000203	0.00117	CcSEcCtD
Quazepam—Asthenia—Epirubicin—hematologic cancer	0.00019	0.0011	CcSEcCtD
Quazepam—Dizziness—Methotrexate—hematologic cancer	0.000187	0.00108	CcSEcCtD
Quazepam—Headache—Methotrexate—hematologic cancer	0.000177	0.00102	CcSEcCtD
Quazepam—Asthenia—Doxorubicin—hematologic cancer	0.000176	0.00102	CcSEcCtD
Quazepam—Dizziness—Epirubicin—hematologic cancer	0.000175	0.00101	CcSEcCtD
Quazepam—Headache—Epirubicin—hematologic cancer	0.000166	0.000959	CcSEcCtD
Quazepam—Flunitrazepam—UGT1A1—hematologic cancer	0.000165	0.389	CrCbGaD
Quazepam—Dizziness—Doxorubicin—hematologic cancer	0.000162	0.000936	CcSEcCtD
Quazepam—Headache—Doxorubicin—hematologic cancer	0.000153	0.000887	CcSEcCtD
Quazepam—Midazolam—SLC22A1—hematologic cancer	9.88e-05	0.233	CrCbGaD
Quazepam—Clonazepam—ALB—hematologic cancer	5.04e-05	0.119	CrCbGaD
Quazepam—Flurazepam—ABCB1—hematologic cancer	3.1e-05	0.073	CrCbGaD
Quazepam—Midazolam—ABCB1—hematologic cancer	2.87e-05	0.0677	CrCbGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.81e-05	0.000316	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—HRAS—hematologic cancer	2.78e-05	0.000313	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	2.78e-05	0.000312	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.73e-05	0.000307	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.72e-05	0.000306	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.69e-05	0.000303	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—MDM2—hematologic cancer	2.68e-05	0.000301	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—HRAS—hematologic cancer	2.65e-05	0.000298	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SMPD3—hematologic cancer	2.64e-05	0.000297	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.64e-05	0.000297	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PHYH—hematologic cancer	2.64e-05	0.000297	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—FTCD—hematologic cancer	2.64e-05	0.000297	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GMPS—hematologic cancer	2.64e-05	0.000297	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.61e-05	0.000294	CbGpPWpGaD
Quazepam—Diazepam—ALB—hematologic cancer	2.58e-05	0.0608	CrCbGaD
Quazepam—GABRB3—BDNF signaling pathway—AKT1—hematologic cancer	2.57e-05	0.000289	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.55e-05	0.000287	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.54e-05	0.000285	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.52e-05	0.000284	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.48e-05	0.00028	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.48e-05	0.000279	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.46e-05	0.000277	CbGpPWpGaD
Quazepam—Diazepam—ABCB1—hematologic cancer	2.46e-05	0.058	CrCbGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.46e-05	0.000276	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SMPD3—hematologic cancer	2.41e-05	0.000271	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.4e-05	0.000271	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.4e-05	0.00027	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ALB—hematologic cancer	2.36e-05	0.000265	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.33e-05	0.000262	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.32e-05	0.000261	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—B3GAT1—hematologic cancer	2.31e-05	0.00026	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ASNS—hematologic cancer	2.31e-05	0.00026	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DCK—hematologic cancer	2.31e-05	0.00026	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.29e-05	0.000258	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.27e-05	0.000255	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.26e-05	0.000254	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.25e-05	0.000253	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.25e-05	0.000253	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	2.24e-05	0.000252	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.24e-05	0.000252	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.23e-05	0.000251	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.19e-05	0.000247	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HDC—hematologic cancer	2.19e-05	0.000246	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.19e-05	0.000246	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—HRAS—hematologic cancer	2.18e-05	0.000246	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—HRAS—hematologic cancer	2.15e-05	0.000242	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DCK—hematologic cancer	2.11e-05	0.000237	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—B3GAT1—hematologic cancer	2.11e-05	0.000237	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ASNS—hematologic cancer	2.11e-05	0.000237	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.08e-05	0.000235	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.06e-05	0.000232	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.06e-05	0.000232	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.06e-05	0.000231	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.04e-05	0.00023	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.02e-05	0.000228	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CDA—hematologic cancer	2e-05	0.000225	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HDC—hematologic cancer	2e-05	0.000225	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.99e-05	0.000224	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.98e-05	0.000222	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.94e-05	0.000218	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.93e-05	0.000217	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PC—hematologic cancer	1.93e-05	0.000217	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.92e-05	0.000216	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.89e-05	0.000213	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GBA—hematologic cancer	1.86e-05	0.00021	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLC35B2—hematologic cancer	1.86e-05	0.00021	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.86e-05	0.00021	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.86e-05	0.000209	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.85e-05	0.000208	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CDA—hematologic cancer	1.83e-05	0.000206	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.82e-05	0.000204	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—HRAS—hematologic cancer	1.79e-05	0.000201	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PC—hematologic cancer	1.76e-05	0.000198	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—HRAS—hematologic cancer	1.75e-05	0.000197	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PHYH—hematologic cancer	1.74e-05	0.000196	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GMPS—hematologic cancer	1.74e-05	0.000196	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—FTCD—hematologic cancer	1.74e-05	0.000196	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—HRAS—hematologic cancer	1.72e-05	0.000194	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—HRAS—hematologic cancer	1.71e-05	0.000193	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MTAP—hematologic cancer	1.7e-05	0.000192	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GBA—hematologic cancer	1.7e-05	0.000191	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.7e-05	0.000191	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.7e-05	0.000191	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—HRAS—hematologic cancer	1.68e-05	0.000189	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.59e-05	0.000179	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.59e-05	0.000179	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MTAP—hematologic cancer	1.55e-05	0.000175	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—FHL2—hematologic cancer	1.52e-05	0.000171	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—AGRN—hematologic cancer	1.49e-05	0.000168	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—HRAS—hematologic cancer	1.47e-05	0.000165	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—IDH2—hematologic cancer	1.41e-05	0.000159	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HMMR—hematologic cancer	1.41e-05	0.000159	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ASNS—hematologic cancer	1.39e-05	0.000156	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.39e-05	0.000156	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DCK—hematologic cancer	1.39e-05	0.000156	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—FHL2—hematologic cancer	1.38e-05	0.000156	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—AGRN—hematologic cancer	1.36e-05	0.000153	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.33e-05	0.00015	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ARNTL—hematologic cancer	1.33e-05	0.000149	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HDC—hematologic cancer	1.32e-05	0.000148	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CA9—hematologic cancer	1.29e-05	0.000145	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ACP5—hematologic cancer	1.29e-05	0.000145	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HMMR—hematologic cancer	1.29e-05	0.000145	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—IDH2—hematologic cancer	1.29e-05	0.000145	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NCOR2—hematologic cancer	1.27e-05	0.000143	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—IDH1—hematologic cancer	1.21e-05	0.000137	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.21e-05	0.000137	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.21e-05	0.000136	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CDA—hematologic cancer	1.2e-05	0.000136	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTO1—hematologic cancer	1.2e-05	0.000135	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TXN—hematologic cancer	1.2e-05	0.000135	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCC3—hematologic cancer	1.2e-05	0.000135	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CA9—hematologic cancer	1.18e-05	0.000132	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ACP5—hematologic cancer	1.18e-05	0.000132	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SPHK1—hematologic cancer	1.17e-05	0.000132	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.16e-05	0.000131	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PC—hematologic cancer	1.16e-05	0.00013	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—UGT1A1—hematologic cancer	1.13e-05	0.000127	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.12e-05	0.000126	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GBA—hematologic cancer	1.12e-05	0.000126	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—IDH1—hematologic cancer	1.11e-05	0.000125	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CRABP1—hematologic cancer	1.1e-05	0.000124	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLC22A1—hematologic cancer	1.1e-05	0.000124	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.09e-05	0.000123	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TXN—hematologic cancer	1.09e-05	0.000123	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.09e-05	0.000123	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.07e-05	0.000121	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALOX5—hematologic cancer	1.07e-05	0.00012	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NUP98—hematologic cancer	1.04e-05	0.000117	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.03e-05	0.000116	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MTAP—hematologic cancer	1.02e-05	0.000115	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ADCY7—hematologic cancer	1.01e-05	0.000113	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NCOA3—hematologic cancer	1.01e-05	0.000113	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1e-05	0.000113	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CRABP1—hematologic cancer	1e-05	0.000113	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NUP214—hematologic cancer	9.99e-06	0.000112	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.88e-06	0.000111	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCG2—hematologic cancer	9.78e-06	0.00011	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MTR—hematologic cancer	9.78e-06	0.00011	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALOX5—hematologic cancer	9.75e-06	0.00011	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ENO2—hematologic cancer	9.59e-06	0.000108	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NUP98—hematologic cancer	9.45e-06	0.000106	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTT1—hematologic cancer	9.31e-06	0.000105	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ADCY7—hematologic cancer	9.17e-06	0.000103	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NCOA3—hematologic cancer	9.17e-06	0.000103	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.16e-06	0.000103	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—FHL2—hematologic cancer	9.13e-06	0.000103	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NUP214—hematologic cancer	9.11e-06	0.000102	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SDC1—hematologic cancer	9.1e-06	0.000102	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.01e-06	0.000101	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—AGRN—hematologic cancer	8.95e-06	0.000101	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MTR—hematologic cancer	8.92e-06	0.0001	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCG2—hematologic cancer	8.92e-06	0.0001	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ENO2—hematologic cancer	8.75e-06	9.84e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.69e-06	9.78e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.58e-06	9.65e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HMMR—hematologic cancer	8.49e-06	9.55e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—IDH2—hematologic cancer	8.49e-06	9.55e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTT1—hematologic cancer	8.48e-06	9.55e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.35e-06	9.4e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SDC1—hematologic cancer	8.29e-06	9.33e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.2e-06	9.23e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ARNTL—hematologic cancer	7.98e-06	8.98e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.92e-06	8.91e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.82e-06	8.8e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CA9—hematologic cancer	7.76e-06	8.74e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ACP5—hematologic cancer	7.76e-06	8.74e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CD44—hematologic cancer	7.73e-06	8.7e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NQO1—hematologic cancer	7.73e-06	8.7e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.66e-06	8.62e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.57e-06	8.52e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.48e-06	8.42e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYCS—hematologic cancer	7.32e-06	8.23e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—IDH1—hematologic cancer	7.3e-06	8.21e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	7.27e-06	8.18e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.22e-06	8.12e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.22e-06	8.12e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TXN—hematologic cancer	7.22e-06	8.12e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.06e-06	7.95e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CD44—hematologic cancer	7.05e-06	7.93e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NQO1—hematologic cancer	7.05e-06	7.93e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.9e-06	7.77e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.79e-06	7.64e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYCS—hematologic cancer	6.67e-06	7.51e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	6.63e-06	7.46e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.6e-06	7.43e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.6e-06	7.43e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.54e-06	7.36e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTP1—hematologic cancer	6.45e-06	7.26e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.43e-06	7.24e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.24e-06	7.02e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NUP98—hematologic cancer	6.23e-06	7.01e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCB1—hematologic cancer	6.11e-06	6.87e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.05e-06	6.81e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.05e-06	6.81e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NUP214—hematologic cancer	6.01e-06	6.76e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.97e-06	6.71e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NCOR1—hematologic cancer	5.93e-06	6.67e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTM1—hematologic cancer	5.93e-06	6.67e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MTR—hematologic cancer	5.88e-06	6.62e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.88e-06	6.62e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTP1—hematologic cancer	5.88e-06	6.62e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ENO2—hematologic cancer	5.77e-06	6.49e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.69e-06	6.4e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.6e-06	6.3e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCB1—hematologic cancer	5.57e-06	6.26e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SDC1—hematologic cancer	5.47e-06	6.15e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.4e-06	6.08e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.4e-06	6.08e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MTHFR—hematologic cancer	5.24e-06	5.89e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.78e-06	5.37e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CD44—hematologic cancer	4.65e-06	5.23e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NQO1—hematologic cancer	4.65e-06	5.23e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.62e-06	5.19e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PIK3CG—hematologic cancer	4.4e-06	4.95e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYCS—hematologic cancer	4.4e-06	4.95e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.37e-06	4.92e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.21e-06	4.74e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.08e-06	4.59e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.01e-06	4.52e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.88e-06	4.36e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.87e-06	4.35e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALB—hematologic cancer	3.82e-06	4.3e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.72e-06	4.19e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.67e-06	4.13e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.65e-06	4.11e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.56e-06	4.01e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.56e-06	4.01e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.53e-06	3.97e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALB—hematologic cancer	3.48e-06	3.92e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.37e-06	3.79e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.33e-06	3.75e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.15e-06	3.54e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.08e-06	3.46e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PTEN—hematologic cancer	2.91e-06	3.28e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—EP300—hematologic cancer	2.78e-06	3.13e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PTEN—hematologic cancer	2.66e-06	2.99e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.65e-06	2.98e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—EP300—hematologic cancer	2.53e-06	2.85e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.45e-06	2.76e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.33e-06	2.62e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALB—hematologic cancer	2.3e-06	2.58e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.2e-06	2.47e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.06e-06	2.31e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.03e-06	2.28e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.87e-06	2.11e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PTEN—hematologic cancer	1.75e-06	1.97e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—AKT1—hematologic cancer	1.68e-06	1.89e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—EP300—hematologic cancer	1.67e-06	1.88e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—AKT1—hematologic cancer	1.53e-06	1.72e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.24e-06	1.39e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—AKT1—hematologic cancer	1.01e-06	1.14e-05	CbGpPWpGaD
